| Title | Author(s) | Year | View Count |
 | World gastroenterology organisation global guideline: Helicobacter pylori in developing countries | Hunt, RH; Xiao, SD; Megraud, F; LeonBarua, R; Bazzoli, F; Van Der Merwe, S; Vaz Coelho, LG; Fock, M; Fedail, S; Cohen, H; Malfertheiner, P; Vakil, N; Hamid, S; Goh, KL; Wong, BCY; Krabshuis, J; Le Mair, A | 2011 | 48 |
| Helicobacter pylori in developing countries. World gastroenterology organisation global guideline | Hunt, RH; Xiao, SD; Megraud, F; LeonBarua, R; Bazzoli, F; Van Der Merwe, S; Vaz Coelho, LG; Fock, M; Fedail, S; Cohen, H; Malfertheiner, P; Vakil, N; Hamid, S; Goh, KL; Wong, BCY; Krabshuis, J; Le Mair, A | 2011 | 63 |
| World Gastroenterology Organisation Global Guidelines: Helicobacter pylori in developing countries August 2010 | Hunt, RH; Xiao, SD; Megraud, F; LeonBarua, R; Bazzoli, F; Van Der Merwe, S; Vaz Coelho, LG; Fock, M; Fedail, S; Cohen, H; Malfertheiner, P; Vakil, N; Hamid, S; Goh, KL; Wong, BCY; Krabshuis, J; Le Mair, A | 2011 | 46 |
| Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers | Tulassay, Z; Stolte, M; Engstrand, L; Butruk, E; Malfertheiner, P; Dt, P; Tchernev, K; Wong, BCY; Gottlow, M; Eklund, S; Wrangstadh, M; Herszényi, L; Nagy, P | 2010 | 64 |
| Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients | Tulassay, Z; Stolte, M; Sjölund, M; Engstrand, L; Butruk, E; Malfertheiner, P; Dite, P; Tchernev, K; Wong, BCY; Gottlow, M; Eklund, S; Wrangstadh, M; Nagy, P | 2008 | 116 |
| The Montreal definition and classification of gastroesophageal reflux disease: A global, evidence-based consensus paper | Die Montreal-definition und -klassifikation der gastroösophagealen refluxkrankheit: Ein globales evidenzbasiertes konsensus-papier | Van Zanten, SV; Kahrilas, P; Dent, J; Jones, R; Vakil, N; Agreus, L; Armstrong, D; Attwood, S; Bergman, JF; Bigard, MA; Blount, P; Bytzer, P; Chiba, T; Delle Fave, G; ElSerag, H; Fan, D; Fass, R; Flook, N; Galmiche, JP; Hongo, M; Iga, FH; Jankowski, J; Johnson, D; Johnssorn, F; Katelaris, P; Kinoshita, Y; KlinkenbergKnol, E; Labenz, J; Liker, H; Malfertheiner, P; Miwa, H; Moayyedi, P; Pace, F; Prado, J; Richter, J; Salis, G; SanRen, L; Sharma, P; Stanghellini, V; Tack, J; Talley, N; Wong, B; Yaozong, Y; Zapata, C | 2007 | 88 |
 | Peroxisome proliferator-activated receptor gamma activation inhibits tumor progression in hepatocellular carcinoma in vitro and in vivo | Yu, J; Qiao, L; Zimmermann, L; Francisco, R; Ebert, M; Lin, W; Teoh, N; Rocken, C; Malfertheiner, P; Farrell, G | 2006 | 119 |
| Expression of peroxisome proliferator-activated receptor δ in human gastric cancer and its response to specific COX-2 inhibitor | Yu, J; Leung, WK; Chen, J; Ebert, MPA; Malfertheiner, P; Sung, JJY | 2005 | 49 |
| Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer | Yu, J; Leung, WK; Ebert, MPA; Leong, RWL; Tse, PCH; Chan, MWY; Bai, AHC; To, KF; Malfertheiner, P; Sung, JJY | 2003 | 53 |
| Expression of trefoil peptides (TFFI, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues | Leung, WK; Yu, J; Chan, FKL; To, KF; Chan, MWY; Ebert, MPA; Ng, EKW; Chung, SCS; Malfertheiner, P; Sung, JJY | 2002 | 53 |
| Increased expression of survivin in gastric cancer patients and in first degree relatives | Yu, J; Leung, WK; Ebert, MPA; Ng, EKW; Go, MYY; Wang, HB; Chung, SCS; Malfertheiner, P; Sung, JJY | 2002 | 78 |
| Effect of Helicobacter pylori eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasia | Yu, J; Leung, WK; Ng, EKW; To, KF; Ebert, MPA; Go, MYY; Chan, WY; Chan, FKL; Chung, SCS; Malfertheiner, P; Sung, JJY | 2001 | 51 |
|
